Arizona will see its first medical school in Flagstaff as part of the Arizona Board of Regents’ call to its public universities to close the health care workforce gap in the state.Continue reading→

AZBio Board Member Dr. Steve Potts discusses the negative impacts provisions of the Inflation Reduction Act (IRA) are having on the health innovation pipeline with Duane Schulthess, Managing Director of Vital Transformation, on the Vital Health Podcast.Continue reading→

Using click-release proteolysis targeting chimeras, researchers have developed a new method of activating specific molecules to target cancer cells without harming healthy cells.Continue reading→

PHOENIX (Sept. 26, 2023) – Newsweek has again named Barrow Neurological Institute one of the World’s Best Specialized Hospitals for Neurosurgery.

In its third year of ranking hospitals in neurosurgery, the media company continues to recognize Barrow as No. 1 in the Southwest and No. 10 in the nation. The Institute climbed two spots globally, sitting at No. 13 for 2024. The list includes 125 hospitals total.Continue reading→

PriZm Therapeutics, a late-stage clinical biotech company with a focus on rare pediatric orphan diseases and BIO’s Seed-Stage Start-Up Stadium winner was featured nationally  and Internationally in BIO News.  Continue reading→

Thanks to a collaboration between the Office of the Maricopa County School Superintendent and the Flinn Foundation, Arizona Bioscience Week will be celebrated in classrooms across Arizona as teachers and students explore pathways to life science and bioscience careers.Continue reading→

San Francisco, CA — September 21, 2023 — Illumina Ventures today announced that Mara Aspinall, MBA, has joined the Company’s investment team as a Partner.
Continue reading→

AZBio Board Member Dr. Steve Potts was in Washington, D.C. on  Wednesday, September 20, 2023.  He testified in the Subcommittee on Oversight and Investigations of the House Energy and Commerce Committee on how the Inflation Reduction Act’s price setting provisions are already raising the hurdles for health innovators as they race to develop new small molecule treatments and cures. Continue reading→

SCOTTSDALE, Ariz. — Sept. 19, 2023 — HonorHealth Research Institute is ushering in a new era of heart pacemakers for patients with abnormal or slow heart rhythms by helping secure FDA approval of the world’s first dual chamber leadless pacemaker.Continue reading→

Comprehensive online program allows patients, caregivers, and families education, tools, and support systems specific to caring for cancer patients of all kinds.Continue reading→